Loading...
Switching to Aflibercept in Diabetic Macular Edema Not Responding to Ranibizumab and/or Intravitreal Dexamethasone Implant
PURPOSE: To assess short-term functional and anatomical outcomes of refractory diabetic macular edema (DME) following a switch from ranibizumab or dexamethasone to aflibercept. METHODS: We included retrospectively eyes with persistent DME after at least 3 ranibizumab and/or one dexamethasone implant...
Na minha lista:
| Udgivet i: | J Ophthalmol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5576400/ https://ncbi.nlm.nih.gov/pubmed/28900543 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8035013 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|